Value proposition

AI for Faster Rare Disease Diagnosis | Scalable PaaS Solutions for Hospitals & Pharma

Saventic Health develops AI-powered platforms to accelerate rare disease diagnosis and improve patient outcomes worldwide.

- AI-powered rare disease diagnosis: Our advanced algorithms analyze electronic health records (EHR) to identify potential rare diseases earlier and with greater accuracy.

- Valuable clinical insights: We equip clinicians with actionable data, streamlining decision-making and reducing diagnostic delays.

- Global presence: We operate in Brazil, Canada, Colombia, Germany, Panama, Poland, and Taiwan, driving impact across healthcare systems worldwide.

- Patient-centered innovation: Committed to improving patient outcomes, we continuously refine our platforms to better serve healthcare providers and their patients.


Current Rare Diseases algorithms available in our portfolio:
- Fabry Disease
- Gaucher Disease
- Hereditary Angioedema (HAE)
- Castleman Disease
- Niemann-Pick (ASMD)
- Mucopolysaccharidosis (MPS)
- Cutaneous T-cell Lymphoma (CTCL)
- Hypophosphatasia (HPP)
- Primary Immunodeficiency (PID)
- Lysosomal Acid Lipase Deficiency (LAL-D)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Myelodysplastic syndromes (MDS)
- Amyloidosis

We also develop tailor-made algorithms for different rare medical conditions.

Learn more about our services on our website.

Artificial Intelligence, Rare Diseases Diagnosis, Precision Medicine, Electronic Health Records (EHR) Analysis, Clinical Decision Support, Early Rare Diseases Detection, Data-Driven Healthcare, Medical Data Analysis, AI-Based Patient Screening, Rare Disease Risk Assessment, Pharma AI Solutions, Neurological Rare Diseases, Hematologic Disorders, Rare Cancer Diagnosis, Rare Cardiovascular Diseases, and Pediatric Rare Diseases